Molson Coors is facing pressure from US glass supply which it expects will continue to impact its volumes in the second quarter. In its first-quarter results yesterday (30 April), the Staropramen brand owner said its outlook for 2026 included a 6-9% decline in US "financial volumes", including sales of the company's "owned or actively managed brands", as well as "contract brewing, wholesale non-owned brand volume and company-owned distribution volume". Speaking to analysts on Thursday, CFO Tracey Jouber ...